MedPath

ISDIN SA

ISDIN SA logo
🇪🇸Spain
Ownership
Joint Venture
Established
1975-01-01
Employees
1K
Market Cap
-
Website
http://www.isdin.com

Clinical Trials

10

Active:4
Completed:6

Trial Phases

2 Phases

Phase 4:1
Not Applicable:3

Drug Approvals

44

CIMA_AEMPS:44

Drug Approvals

TACTUOBEN 1 mg/g + 25 mg/g GEL

Approval Date
Jul 14, 2025
Company
laboratorios galderma s.a.
CIMA_AEMPS

HONGOSERIL 100 mg CAPSULAS

Approval Date
Jul 14, 2025
CIMA_AEMPS

LAMBDALINA 40 mg/g CREMA

Approval Date
Jul 14, 2025
CIMA_AEMPS

MUPIROCINA ISDIN 20 mg/g POMADA

Approval Date
Jul 14, 2025
CIMA_AEMPS

CALCIO D ISDIN 600 MG/400 UI COMPRIMIDOS MASTICABLES

Approval Date
Jul 14, 2025
CIMA_AEMPS

BONALFA 4 MICROGRAMOS/G POMADA

Approval Date
Jul 14, 2025
CIMA_AEMPS

PEROXIBEN 100 mg/g GEL

Approval Date
Jul 14, 2025
CIMA_AEMPS

NUTRACEL POMADA

Approval Date
Jul 14, 2025
CIMA_AEMPS

ANTIVERRUGAS ISDIN COLODION

Approval Date
Jul 14, 2025
CIMA_AEMPS

ACNISDIN 20 MG CAPSULAS BLANDAS EFG

Approval Date
Jul 14, 2025
CIMA_AEMPS
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (75.0%)
Phase 4
1 (25.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.